Exploring Traditional Chinese Medicine Factors in Lung Cancer
A Study on the Correlation Between TCM Constitution, Pattern Types, and Disease Factors in Primary Lung Cancer.
This study looks at how Traditional Chinese Medicine factors relate to lung cancer in patients to better understand their disease characteristics.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 250 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | China Medical University Hospital Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy, radiation |
| Locations | 1 site (Taichung City) |
| Trial ID | NCT06143436 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the relationship between Traditional Chinese Medicine (TCM) constitution, pattern identification, and various factors in patients diagnosed with primary lung cancer in Taiwan. The research will involve interviewing patients in the thoracic ward and outpatient clinic of China Medical University Hospital from November 2023 to May 2025. By collecting demographic data and utilizing a Constitution in Chinese Medicine Questionnaire, the study aims to uncover the disease characteristics of lung cancer through the lens of TCM theory.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 to 100 diagnosed with primary lung cancer who can provide informed consent.
Not a fit: Patients with severe mental illness, other primary malignancies, or those who have undergone significant cancer treatments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of lung cancer characteristics and improve TCM-based treatment approaches.
How similar studies have performed: While there have been various studies on TCM and lung cancer, this specific approach focusing on constitution and pattern identification is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with primary lung cancer. * Age greater than 18 years and less than 100 years. * After explanation, they agree to join this study and voluntarily sign the subject consent form, and can understand the content of the questionnaire. Exclusion Criteria: * Pregnant women. * Severe mental illness that affects the response to the questionnaire. * Has been treated (e.g., surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, etc.). * Concomitant with other uncured primary malignancies. * Patients with other serious primary diseases (such as: liver and kidney dysfunction, hematolymphatic system diseases, etc.). * Severe respiratory diseases that are not lung cancer (e.g. primary emphysema, interstitial fibrosis, etc.) .
Where this trial is running
Taichung City
- China Medical University Hospital — Taichung City, Taiwan (Recruiting)
Study contacts
- Study coordinator: Su-Tso Yang, M.D.
- Email: 002794@tool.caaumed.org.tw
- Phone: 886-4-22052121
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.